Literature DB >> 1087213

Lymphocytotoxins in acute and chronic hepatitis. Characterization and relationship to changes in circulating T lymphocytes.

R J Dehoratius, C Henderson, R G Strickland.   

Abstract

Serum lymphocytotoxicity (LCT) was detected in 49% of fifty-one patients with acute viral hepatitis and 72% of twenty-nine patients with chronic hepatitis. LCT was not detected in ten chronic carriers of hepatitis B surface antigen. Characterization of LCT revealed it to be active at physiologic temperatures and to be reactive against both T and B lymphocytes. The occurrence of LCT was transient in acute hepatitis and intermittent in chronic hepatitis. There was a significant inverse relationship between the percentage change in LCT over time and peripheral blood T-cell proportions amongst the patients studied. These findings indicate the importance of liver damage in the appearance of LCT and suggest that LCT may contribute to depressed lymphocyte function in liver disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 1087213      PMCID: PMC1540808     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  MICRODROPLET ASSAY OF HUMAN SERUM CYTOTOXINS.

Authors:  P I TERASAKI; J D MCCLELLAND
Journal:  Nature       Date:  1964-12-05       Impact factor: 49.962

2.  Relative T-cell specificity of lymphocytotoxins from patients with systemic lupus erythematosus.

Authors:  R B Lies; R P Messner; R C Williams
Journal:  Arthritis Rheum       Date:  1973 May-Jun

3.  Lymphocyte function in normal people with persistent Australia antigen.

Authors:  A I Sutnick; S J Bugbee; W T London; L A Loeb; F Peyretti; S Litwin; B S Blumberg
Journal:  J Lab Clin Med       Date:  1973-07

4.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

5.  Inadequate antibody response to hBAg or suppressor T-cell defect in development of active chronic hepatitis.

Authors:  A L Eddleston; R Williams
Journal:  Lancet       Date:  1974-12-28       Impact factor: 79.321

6.  Separation of cells according to surface antigens by the use of antibody-coated columns. Fractionation of cells carrying immunoglobulins and blood group antigen.

Authors:  H Wigzell; K G Sundqvist; T O Yoshida
Journal:  Scand J Immunol       Date:  1972       Impact factor: 3.487

7.  Lymphocyte stimulation in hepatitis B infections.

Authors:  M J Tong; A M Wallace; R L Peters; T B Reynolds
Journal:  N Engl J Med       Date:  1975-08-14       Impact factor: 91.245

8.  Peripheral blood lymphocyte cell surface markers during the course of systemic lupus erythematosus.

Authors:  R P Messner; F D Lindström; R C Williams
Journal:  J Clin Invest       Date:  1973-12       Impact factor: 14.808

9.  Localization of T and B cells and alpha fetoprotein in hepatic biopsies from patients with liver disease.

Authors:  G Husby; R G Strickland; J L Caldwell; R C Williams
Journal:  J Clin Invest       Date:  1975-11       Impact factor: 14.808

10.  Studies of T- and B-lymphocytes in patients with connective tissue diseases.

Authors:  R C Williams; J R DeBoard; O J Mellbye; R P Messner; F D Lindström
Journal:  J Clin Invest       Date:  1973-02       Impact factor: 14.808

View more
  13 in total

1.  Anti-lymphocytic antibodies in autoimmune chronic active hepatitis starting in childhood.

Authors:  P T Donaldson; M J Hussain; G Mieli-Vergani; A P Mowat; D Vergani
Journal:  Clin Exp Immunol       Date:  1989-01       Impact factor: 4.330

Review 2.  Immunological changes in liver disease.

Authors:  S Sherlock
Journal:  Proc R Soc Med       Date:  1977-12

3.  Active E rosette-forming cells in the peripheral blood of patients with chronic active hepatitis.

Authors:  M C de Moura; F Ramalho
Journal:  Dig Dis Sci       Date:  1979-07       Impact factor: 3.199

4.  Disordered immunoregulatory functions in patients with chronic active hepatitis.

Authors:  A Nonomura; M Tanino; H Kurumaya; G Ohta; Y Kato; K Kobayashi
Journal:  Clin Exp Immunol       Date:  1982-03       Impact factor: 4.330

5.  Cold-reactive lymphocytotoxins in Crohn's disease and ulcerative colitis. I. Incidence and characterization.

Authors:  D J Brown; D P Jewell
Journal:  Clin Exp Immunol       Date:  1982-07       Impact factor: 4.330

Review 6.  Autoantibodies and serum inhibition factors (sif) in patients with myocarditis.

Authors:  B Maisch; P A Berg; K Kochsiek
Journal:  Klin Wochenschr       Date:  1980-03-03

7.  Lymphocytotoxic antibodies in patients with inflammatory bowel disease and their spouses--evidence for a transmissible agent.

Authors:  R G Strickland; W C Miller; N A Volpicelli; R F Gaeke; I D Wilson; J B Kirsner; R C Williams
Journal:  Clin Exp Immunol       Date:  1977-11       Impact factor: 4.330

8.  Cold-reactive immunoglobulin M antilymphocyte antibodies directed against B cells in Thai children with dengue hemorrhagic fever.

Authors:  M J Gilbreath; K Pavanand; R P MacDermott; M Ussery; D S Burke; S Nimmannitya; S Tulyayon
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

9.  Lymphocytotoxic antibodies in primary biliary cirrhosis.

Authors:  A Parés; J Martorell; J Caballería; J Vives; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

10.  Mitogen responsiveness in viral hepatitis and chronic active hepatitis: the role of reversible suppressive influences.

Authors:  C Feighery; J F Greally; D G Weir
Journal:  Gut       Date:  1980-09       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.